CRH
CRH plc
$83.18
-0.54% 2026-10-19
MaterialsS&P 500
CRHSPY
1W
+2.6%
1M
-3.4%
3M
-16.4%
6M
-29.3%
YTD
-32.6%
1Y
-28.4%
Grades vs sector
Momentum5th pct in sectorF
Momentum
5th pct in sector
12-1 return: -29.7%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth34th pct in sectorC-
Growth
34th pct in sector
Revenue growth (YoY): +5.6%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value56th pct in sectorC+
Value
56th pct in sector
Forward E/P: 7.7% · EBITDA/EV: 10.5%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability74th pct in sectorB+
Profitability
74th pct in sector
Profit margin: +9.9% · Return on equity: +15.8%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
rank 447 of 499 · 12-1 momentum % -20.5
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$55.3B
P/E (trailing)14.7
P/E (forward)13.0
52-week range78.62 – 131.55
Revenue growth (YoY, latest qtr)+5.6%
Dividend yield1.87%
Analyst consensusStrong Buy (24)
Mean price target$124.79 (+50%)
Valuation & fundamentals
Bottom line
Leans expensive
Model read-out from the numbers below, not advice. Score -1 (DCF counts double).
▼DCF (base case)below the price by 43%
•Forward P/E vs sector13.0x vs median 12.7x
•Piotroski F-score6/9
•Altman Z2.7 (grey)
•Net debt / EBITDA1.9x
▲Analyst target+50% (24 analysts)
Discounted cash flow
CyclicalValued on average-cycle margins
Construction Materials profits swing with the business cycle, so one year's cash flow can be far above or below normal. Instead of the last 12 months' free cash flow (2.7B, a 7% margin), the DCF and reverse DCF use the average free-cash-flow margin over FY2021–FY2025 (5 years: 7.8%) times current revenue = 3.0B. On trailing cash flow the base case would be $40; on mid-cycle cash flow it is $47. Glossary
Bear
$23
-72%
growth 0% · disc. 11.2% · term. 2.0%
Base
$47
-43%
growth 5% · disc. 10.2% · term. 2.5%
Bull
$78
-6%
growth 8% · disc. 9.2% · term. 3.0%
Starting cash flow is mid-cycle: 7.8% average margin × current revenue = 3.0B (last 12 months: 2.7B at a 7% margin). On trailing cash flow the base case would be $40.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 10% a year for 10 years.
Implied
+10%/yr
FCF, last 3 yrs
+9%/yr
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+5%/yr
Revenue, last 5 yrs
n/a
Same inputs as the DCF above: mid-cycle free cash flow 3.0B, 10.2% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.19 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
P/E (trailing)
cheaper
sector median 20.6× · 19th pct
14.7×cheaper
Forward P/E
pricier
sector median 12.7× · 53rd pct
13.0×pricier
EV / EBITDA
cheaper
sector median 11.1× · 28th pct
9.0×cheaper
Price / sales
cheaper
sector median 1.4× · 50th pct
1.4×cheaper
Price / book
cheaper
sector median 2.3× · 49th pct
2.3×cheaper
FCF yield
cheaper
sector median 4.7% · 55th pct
4.9%cheaper
Forward EPS $6.42 vs trailing $5.66 (+13% expected growth). Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$3.3B
as of 2026-06-30
vs a year ago
-20%
YoY
× TTM revenue
0.08×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
36.2%
Operating margin
14.3%
FCF margin
7.0%
Net margin
9.9%
Return on equity
16.0%
Return on invested capital
10.7%
Net debt / EBITDA
1.9×
Current ratio
1.6×
Interest cover
6.5×
Cash conversion (OCF/NI)
1.4×
Piotroski F-score 6/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✓ Gross margin improved✗ Asset turnover improved
Altman Z-score 2.7 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$125
+50%
Analysts
24
Strong Buy
Range
$96–$160
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $37.4B | $3.8B | $2.9B |
| 2024 | $35.6B | $3.5B | $2.4B |
| 2023 | $34.9B | $3.2B | $3.2B |
| 2022 | $32.7B | $3.9B | $2.3B |
| 2021 | $29.2B | $2.6B | $2.4B |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +4.6%.
Earnings
Next report: 2026-10-29 · before open · EPS est 2.07
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | 2.02 | 1.93 | -4.2% |
| 2026-04-30 | -0.23 | -0.21 | +8.1% |
| 2026-02-18 | 1.53 | 1.51 | -1.8% |
| 2025-11-05 | 2.21 | 2.23 | +0.9% |
| 2025-08-06 | 1.94 | 1.96 | +0.9% |
| 2025-05-05 | -0.09 | -0.12 | -38.0% |
| 2025-02-26 | 1.42 | 1.18 | -16.8% |
| 2024-11-07 | 2.09 | 1.97 | -5.9% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $10.8B | +5.6% |
| 2026-03-31 | $7.4B | – |
| 2025-12-31 | $9.4B | – |
| 2025-09-30 | $11.1B | – |
| 2025-06-30 | $10.2B | – |
Analyst actions
Barclays
PT $110
2026-10-19 · main
Overweight → OverweightPT $110
RBC Capital
PT $135
2026-10-09 · main
Outperform → OutperformPT $135
Wells Fargo
PT $106
2026-10-05 · main
Overweight → OverweightPT $106
Truist Securities
PT $105
2026-10-05 · main
Buy → BuyPT $105
Citigroup
PT $106
2026-10-02 · main
Buy → BuyPT $106
UBS
PT $135
2026-09-22 · main
Buy → BuyPT $135
Recent dividends
2026-08-14: $0.390 · 2026-05-15: $0.390 · 2026-03-06: $0.390 · 2025-05-23: $0.370 · 2025-03-14: $0.370 · 2024-11-22: $0.350 · 2024-08-23: $0.350 · 2024-05-23: $0.350
News
CRH (CRH) Gains As Market Dips: What You Should Know
Zacks · Oct 16
Barclays Adjusts Price Target on CRH public to $110 From $131
MT Newswires · Oct 16
CRH Confirms Date for Q3 2026 Results
Business Wire · Oct 15
Here's Why CRH (CRH) Fell More Than Broader Market
Zacks · Oct 13
RBC Cuts Price Target on CRH to $135 From $165, Keeps Outperform Rating
MT Newswires · Oct 09
Deutsche Bank Adjusts Price Target on CRH public to $118 From $128
MT Newswires · Oct 09
Does CRH's Nordic Aggregates Deal Add More Fuel to Its Growth Plan?
Zacks · Oct 08
NCC to sell Industry unit to Heidelberg Materials and CRH for $820m
World Construction Network · Oct 08
Stats refreshed 2026-10-19 19:02:24 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.